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The role of Nav1.9 channel in the 
development of neuropathic orofacial pain 
associated with trigeminal neuralgia
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Abstract 
Background: Trigeminal neuralgia is accompanied by severe mechanical, thermal and chemical hypersensitivity 
of the orofacial area innervated by neurons of trigeminal ganglion (TG). We examined the role of the voltage‑gated 
sodium channel subtype Nav1.9 in the development of trigeminal neuralgia.
Results: We found that Nav1.9 is required for the development of both thermal and mechanical hypersensitivity 
induced by constriction of the infraorbital nerve (CION). The CION model does not induce change on Nav1.9 mRNA 
expression in the ipsilateral TG neurons when evaluated 9 days after surgery.
Conclusions: These results demonstrate that Nav1.9 channels play a critical role in the development of orofacial 
neuropathic pain. New routes for the treatment of orofacial neuropathic pain focussing on regulation of the voltage‑
gated Nav1.9 sodium channel activity should be investigated.
Keywords: Nav1.9 sodium channels, Trigeminal ganglion (TG) neurons, Constriction of the infraorbital nerve, 
Trigeminal neuralgia, Neuropathic pain
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Background
Trigeminal neuralgia is an excruciating pain syndrome 
characterized by severe facial pain that can be triggered 
by light touch of the orofacial surface area producing 
stabbing, shooting or burning sensations. Trigeminal 
neuralgia is accompanied by mechanical, thermal and/
or chemical hypersensitivities of the orofacial area and 
is maintained by impaired signaling in sensory neurons 
of trigeminal ganglion (TG) [1]. However, little is known 
about the intracellular mechanisms or altered function-
ing of TG nociceptors underling the development of oro-
facial pain.
Voltage-gated sodium channels play a central role in 
nociception, being key determinants of neuronal excit-
ability. Specific expression of tetrodotoxin-resistant 
(TTX-R) voltage-gated sodium channels Nav1.8 and 
Nav1.9 subtypes was found for a restricted population of 
peripheral nociceptors in TG [2–4], dorsal root ganglion 
(DRG) [5–9], nodose ganglion [10], unmyelinated affer-
ent fibres and nerve terminals [8, 9, 11, 12]. While Nav1.8 
channels carry the majority of inward current during the 
upstroke of the action potentials (AP) [13–15], Nav1.9 
channels sustain repetitive firing and plateau potentials 
[16, 17] due to their characteristic activation at relatively 
negative membrane potentials as well as slow and incom-
plete inactivation, producing “persistent” Na+ flow at 
subthreshold voltages [18–20].
Studies of the role of Nav1.9 channels showed that 
SCN11A null mutant mice developed reduced hyperal-
gesia in different inflammatory pain models [formalin, 
carrageenan, complete freund’s adjuvant (CFA), pros-
taglandin E2] [21, 22] as well as diminished nociceptive 
sensitivity triggered by inflammatory mediators [brady-
kinin, serotonin, adenosine triphosphate (ATP)] [2]. In 
contrast, Nav1.9−/− mice showed unaltered pain-related 
behaviour in models of DRG-related neuropathic pain of 
various origins (partial sciatic nerve injury [2], chronic 
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constriction injury (CCI) [23] and spinal nerve trans-
action [24]). Recent studies of human SCN11A gene 
mutations demonstrated that several mutations in this 
gene are associated with either, peripheral neuropa-
thy and episodic chronic pain [25] or congenital inabil-
ity to experience pain [26]. Despite the established role 
of Nav1.9 channels in pain perception, the contribution 
of this channel subtype to the development of orofacial 
pain remains unknown, and how cephalic neuropathic 
pain develops with loss of Nav1.9 channels has not been 
studied.
Using global Nav1.9 knockout mice, we show for the 
first time that loss of Nav1.9 channels is associated with 
the failure to develop orofacial pain in a model of trigem-
inal neuralgia.
Results
Basal orofacial sensitivity in Nav1.9
+/+ and Nav1.9
−/− mice
To examine if the loss of Nav1.9 channels could 
influence the sensitivity of the orofacial area, basal 
mechanical and thermal sensitivities were examined 
in Nav1.9+/+ and Nav1.9–/– mice. Mechanical orofa-
cial sensitivity was evaluated as a functional reaction 
in response to 0.04  g von Frey filament applied to the 
animal forehead innervated by the trigeminal nerve 
(Fig. 1a). A filament of 0.04 g intensity was chosen since 
I have been found to evoke nociceptive responses in 
the orofacial area after unilateral constriction of the 
infraorbital nerve (CION), but present almost no effect 
in control mice [27]. No differences in basal responses 
to mechanical stimulation were observed between 
genotypes (n = 13–14 mice, p > 0.05; Fig. 1c). Groups 
did not differ with regard to basal thermal sensitiv-
ity, measured as a latency of response to radiant heat 
applied to the vibrissal pad surface (n  =  13–14 mice, 
p > 0.05; Fig. 1b, d). Thus, loss of Nav1.9 channels does 
not affect basal orofacial sensitivity, either mechanical 
or thermal, in mice.
We next examined the responses of control and knock-
out mice to a sham surgical inflammation without nerve 
damage. No major differences in mechanical and thermal 
sensitivities were found between Nav1.9+/+ and Nav1.9–/– 
mice, submitted to this sham surgical procedure with no 
CION, at different time-points (on days 2, 5, 7, 14, 21 and 
28 post-surgery; n =  13–14 mice; Fig.  1e, f ). Although, 
the orofacial area was sensitised after the sham surgical 
procedure, the surgery-induced changes were similar 
between Nav1.9+/+ and Nav1.9−/− sham-operated mice 
for either threshold mechanical (by 26 %, p < 0.01 and by 
31 %, p < 0.001 in Nav1.9+/+ and Nav1.9−/− mice, respec-
tively; n = 13–14 mice; Fig. 1g) or threshold thermal sen-
sitivities (by 29 % and by 31 %, n = 13–14 mice, p < 0.01 
in Nav1.9+/+ and Nav1.9−/− mice, respectively; Fig. 1h).
Loss of Nav1.9 channels alleviates CION‑induced orofacial 
hypersensitivity
Constriction of the infraorbital nerve [25] led to a devel-
opment of long-lasting mechanical hypersensitivity in 
Nav1.9+/+. This hypersensitivity developed 7  days after 
surgery, reached a peak at 2  weeks, and remained per-
sistent until 3  weeks (Fig.  2a). CION-induced mechani-
cal hypersensitivity was robust, showing a significantly 
increased reaction in response to von Frey filament 
applied to the forehead of Nav1.9+/+ and Nav1.9−/− 
mice. The increase in the response frequency was 26  % 
(p < 0.05), 35 % (p < 0.01) and 31 % (p < 0.01) on day 7, 
14 and 21 after CION respectively compared to sham-
operated mice (n  =  13–14 mice; Fig.  2a). Strikingly, in 
Nav1.9−/− mice, CION was not accompanied by the 
development of hypersensitivity of the orofacial area. 
The responses of Nav1.9−/− mice were similar to those 
observed in the littermates of the sham-operated group 
over all periods tested. Thus, loss of Nav1.9 channels 
abolished the development of CION-induced mechanical 
hypersensitivity.
Loss of Nav1.9 channels also abolished the develop-
ment of CION-induced thermal hypersensitivity. Con-
sistent with previous studies [28], CION produced a 
long-lasting thermal hypersensitivity in Nav1.9+/+ mice, 
which developed within 1 week after surgery. The CION-
induced decrease in thermal latency in Nav1.9+/+ mice 
was 10 % (p < 0.05) on day 7 and 12 % (p < 0.001) on day 
14 post-surgery. However, the latency was not changed 
in Nav1.9−/− mice following CION over all period tested 
(n = 13–14 mice; Fig. 2b). Together, these results indicate 
that the Nav1.9 channel is required for the development 
of neuropathic orofacial pain.
Expression of Nav1.9 mRNA in TG on Sham and CION 
Nav1.9
+/+ mice
As the Nav1.9−/− mice did not develop mechanical or 
thermal hypersensitivity after CION, the next step was 
to evaluate if the CION model induced any change in 
the expression of Nav1.9 mRNA in TG neurons. Sample 
from ipsilateral TG was processed on day 9 after surgery, 
for extraction of mRNA. As showed on Fig. 3, no Nav1.9 
mRNA expression difference was observed between the 
CION (1.06  ±  0.42) and Sham (1.12  ±  0.28) groups in 
Nav1.9+/+ mice (p = 0.9026).
Discussion
Considerable evidence suggests participation of Nav1.9 
channels in the perception of pain. Both gain of function 
and loss of function pain conditions have been associated 
with point mutations in Nav1.9 [25, 26]. Two of those 
mutations led to a reduction in the current threshold and 
increased firing frequency in response to suprathreshold 
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Fig. 1 Loss of Nav1.9 does not influence orofacial sensitivity in mice. Mechanical orofacial sensitivity in response to 0.04 g von Frey filament applied 
to the forehead (a) and thermal orofacial sensitivity in response to radiant heat applied to a vibrissal pad (b) in sham‑operated Nav1.9
+/+ and 
Nav1.9
−/− mice. Mechanical (c) and thermal (d) orofacial sensitivities baselines. Mechanical (e) and thermal (f) orofacial sensitivities evaluated before 
(pre) and at different time‑points after surgery. Changes in mechanical (g) and thermal (h) orofacial sensitivities after sham‑operation. Values repre‑
sent mean ± SEM analysed for 13–14 mice. **p < 0.01, ***p < 0.001 compared to that before surgery (pre) (Student paired t test)
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stimuli [25]. Mutations in SCN11A (R225C and A808G), 
reported in patients experienced episodic chronic pain, 
caused an increase in the Nav1.9 channels-mediated 
current density and hyperexcitability of nociceptive 
DRG neurons without changes in the resting membrane 
potential [29]. Other gain of function mutations lead 
Nav1.9 channels to display excessive activity at resting 
voltages, causing sustained depolarization of nocicep-
tors, impaired generation of action potentials and result-
ing in a pain-free state [26]. The principal mechanism 
by which Nav1.9 channels contribute to painful states 
includes sensitization of nociceptors triggered by genera-
tion of persistent Na+ currents at subthreshold voltages 
that promotes depolarization near the resting mem-
brane potential, reduces the current threshold required 
to trigger an action potential, and results in hyperexcit-
ability of sensory neurons [7, 16, 18–20, 30]. Here using 
Nav1.9−/− mice, we show that Nav1.9 channels are also 
involved in sustained (tonic) firing of nociceptive TG 
neurons and are required for the development of orofa-
cial neuropathic pain.
The role of the Nav1.9 channel in maintaining periph-
eral inflammatory pain has been demonstrated in differ-
ent studies [21, 22, 30]. Inflammatory pain of different 
origins (induced by formalin, carrageenan, CFA, cap-
saicin, ATP, IL-1β or prostaglandin-E2) was substantially 
reduced in Nav1.9−/− mice [21, 22, 30], while neuropathic 
pain, produced by CCI or spinal nerve transection, still 
developed, showing mechanical allodynia of the hind paw 
of Nav1.9−/− mice [24, 31]. Using CION-induced model 
of orofacial neuropathic pain [28, 32], we demonstrate 
here the absence of both mechanical and thermal hyper-
sensitivity of the orofacial area in Nav1.9−/− mice after 
CION. Loss of Nav1.9 channels did not change basal oro-
facial sensitivity (mechanical or thermal), indicating no 
major effects of Nav1.9 deletion on normal nociceptive 
pathways. Our findings of a crucial role for Nav1.9 chan-
nels in the development of neuropathic orofacial pain are 
in contrast with reports showing no critical involvement 
of these channels in the development of neuropathic pain 
in other somatic neuropathic pain models [24, 31]. This 
may reflect distinct mechanisms of neuropathic pain.
Nav1.9 channels enhance sustained repetitive (tonic) 
firing in TG neurons. Previous studies showing that 
Nav1.9 channels maintain sustained repetitive fir-
ing in DRG nociceptors and modulate patterns of fir-
ing discharge, including plateau potentials, active 
a b
Fig. 2 Orofacial neuropathic hypersensitivity was attenuated in Nav1.9 KO mice. Changes in mechanical orofacial sensitivity in response to 0.04 g 
von Frey filament applied to the forehead (a) and thermal orofacial sensitivity in response to radiant heat applied to a ipsilateral vibrissal pad (b) in 
Nav1.9
+/+ and Nav1.9
−/− mice before surgery (pre) and at different time‑point after CION. Values represent mean ± SEM. analysed for 13–14 mice. 
*p < 0.05, **p < 0.01, ***p < 0.001 compared to the correspondent time‑point in sham Nav1.9
+/+ mice (Two‑way ANOVA followed by Bonferroni’s 
test)
Fig. 3 Expression of Nav1.9 mRNA in TG on Sham and CION 
Nav1.9
+/+ mice 9 days after surgery. Values represent mean ± SEM 
analysed for 6–7 mice (Student paired t test)
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hyperpolarizing responses, and sustained oscillatory 
bursting discharges [16, 18, 33]. It is intriguing that gain 
of function Nav1.9 mutations in humans may result in 
enhanced pain or a complete loss of pain sensation [25, 
26]. In transgenic mice, inflammatory pain is associated 
with enhanced Nav1.9 persistent sodium channel activity 
[30]. In the present study, neuropathic pain is depend-
ent on the activity of Nav1.9 in a model of trigeminal 
neuralgia. A critical role for Nav1.9 in regulating pain 
thresholds is thus clear, but the precise mechanisms that 
contribute to the different pain phenotypes remains to be 
established.
Conclusions
Our study demonstrates for the first time that the Nav1.9 
channel plays a critical role in the development of neu-
ropathic orofacial pain associated with trigeminal neu-
ralgia. Understanding how orbital nerve damage leads 
to myofascial pain through the modulation of Nav1.9 
activity may provide new approaches to the treatment of 
trigeminal neuralgia.
Methods
Animals
C57Bl/6 mice (2–3  month-old) were used in accord-
ance with the protocols approved by the UK Home 
Office and UCL ethics committee under a Home Office 
project license. All efforts were made to minimise ani-
mal suffering and to reduce the number of animals 
used. Experiments were conducted using both male and 
female wild type littermate and global Nav1.9 knock-
out mice bred from heterozygous (Nav1.9+/−) animals. 
The generation and characterization of the Nav1.9 null 
mutant line was previously described [34]. Mouse colo-
nies were genotyped by PCR using ear biopsy sam-
ples. Only homozygous Nav1.9-null (Nav1.9−/−) and 
wild type (Nav1.9+/+) mice were used in these stud-
ies. Genomic DNA was extracted using a lysis buffer 
containing (in mM) 67 Tris, 16 (NH4)2SO4, 6.7 MgCl2, 
100 β-mercaptoethanol, and 0.5  % Triton X-100 and 
0.05 mg/ml proteinase K. The primers used were: 5′-AAC 
AGTCTTACGCTGTTCCGATG-3′ (sense), 5′-ATGTG 
GCACTGGGCTTGAACTC-3′ (antisense), 5′-CTCGTC 
GTGACCCATGGCGAT-3′ (Neomycin FW). PCR was 
performed in one reaction and resulted in a 276 bp frag-
ment product for WT and a 600  bp band for knockout 
mice.
Infraorbital nerve constriction
To produce the painful condition of trigeminal neuralgia, 
we used a model of unilateral CION [25] according to a 
method previously described for rats [28, 35] with some 
modifications. Briefly, mice were anesthetized with an 
intramuscular (i.m.) injection of a mixture of ketamine 
(Fort Dodge Animal Health LTD, UK) and medetomidine 
(Orion Pharma, UK) in the doses of 50 and 0.5  mg/kg, 
respectively. One incision was made below the right eye 
1 mm caudal to the myofascial (vibrissal) pads. The supe-
rior lip elevator and anterior superficial masseter muscles 
were dissected to expose the rostral end of the infraor-
bital nerve, as it emerges from the infraorbital fissure. 
Extra care was taken to prevent facial nerve damage. Two 
silk ligatures (No. 8.0, Ethicon) were loosely tied at a dis-
tance of 2 mm around the infraorbital nerve, producing 
a development of orofacial hypersensitivity and prevent-
ing infraorbital nerve destruction [35]. The incision was 
closed with polypropylene sutures (No. 6.0, Ethicon). 
After surgery, all animals were injected i.m. with atipam-
ezole (5 mg/kg, Orion Pharma) and were maintained in 
a warmed area until full recovery from anaesthesia. Ani-
mals operated on an identical manner with no ligature 
applied to the nerve were used as control (sham).
Behavioral tests
Measurement of mechanical hyperalgesia
Mice were acclimatized in an individual animal enclo-
sure (4″ × 4″) chamber for at least 1 h. Sham-operated 
or CION-injured animals were submitted to a repeated 
mechanical stimulus (0.04  g von Frey filament) applied 
to the forehead surface innervated by the trigemi-
nal nerve (Fig.  1a). Each trial was repeated 10 times at 
30-s interval at least. The occurrence of head reactions 
(attack/escape or head withdrawal) was expressed for 
each trial as the mean of percentage reactions that repre-
sents an index of mechanical nociceptive sensitivity [27]. 
To determine basal mechanical sensitivity, the mechani-
cal stimulus was applied to the forehead of animals 1 day 
before surgery. A development of mechanical hyperalge-
sia following CION was estimated at different days after 
surgery.
Measurement of thermal hyperalgesia
Thermal hyperalgesia of the orofacial area was measured 
as previously described [28, 36]. Each animal was held in 
front of a radiant heat source positioned 1 cm from the 
vibrissal pad surface (Fig.  1b). The intensity of thermal 
stimulus applied to the vibrissal pad skin was adjusted 
to temperature of ~50 °C (15 s cut off). Once the animal 
started to withdraw its head or vigorously flick a snout, 
the heat beam was turned off. The time between the 
start of the beam and a functional response was defined 
as a latency of response. A reduction in the response 
latency reflected thermal hyperalgesia. To determine 
basal thermal sensitivity, a heat stimulus was applied to 
the ipsilateral side of the snout 1 day before surgery. Basal 
latency of responses was typically from 10 to 15  s. The 
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development of thermal hyperalgesia following CION 
was measured at different days after surgery.
Nav1.9 expression analysis real‑time PCR
After animal euthanasia (with a CO2 chamber following 
by cervical dislocation), TG was quickly removed and 
placed in buffer RTL and RNA was isolated using RNe-
asy mini kit (Quiagen) according to the manufacturer 
instructions. The RNA was quantified by Nanodrop and 
converted to cDNA using iScript™ reverse transcription 
supermix for qRT-PCR (BioRad) according to the manu-
facturer instructions. PCR amplifications were performed 
using a Mastercycler ep realplex (Eppendorf). All samples 
were run in triplicate in a final volume of 20 µl contain-
ing 10 ng of cDNA, 1 µM of primers and SsoAdvanced™ 
universal SYBR® Green supermix (BioRad), according to 
manufacturer protocol. Prior to PCR, an 8  min enzyme 
activation step was done at 95 °C. The PCR protocol con-
sisted of 10 s denaturation at 95 °C, 5 s at annealing tem-
perature at 63  °C, 10 s elongation at 72  °C for 40 cycles. 
The annealing temperature was confirmed by melting 
curve. The primers sequences used were the following: 
TTCCACTCTACGTACCTTCCGAGT (forward) and 
ATTCCCATGAAGAGCTGCTGACCA (reverse) for 
Nav1.9; TGCGACTTCAACAGCAACTC (forward) and 
CTTGCTCAGTGTCCTTGCTG (reverse) for GAPDH.
Nav1.9 and GAPDH cDNA relative amounts were cal-
culated function of the samples cycle threshold (Ct) using 
a standard concentration curve constructed with a serial 
dilution (10 times) from 100 to 0.01 ng of cDNA mix. For 
each sample, the relative amount of Nav1.9 cDNA was 
normalized by the GAPDH cDNA amount.
Statistical analysis
Data were analyzed using GraphPad Prism 5. The results 
are presented as mean ± SEM with n referring to the num-
ber of animals tested. Multiple groups were compared 
using two-way analysis of variance [37] followed by Bon-
ferroni post hoc test or Student paired t test as indicated.
Values of p less than 0.05 was considered as statistically 
significant for either test used.
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